Effects of Amphetamine and Evoked Dopamine Release on [11C]raclopride Binding in Anesthetized Cats

[1]  M. Laruelle,et al.  Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia , 2000, Biological Psychiatry.

[2]  N. Harada,et al.  Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis , 2000, Synapse.

[3]  M. Laruelle.  Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Hideo Tsukada,et al.  Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain , 1999, Brain Research.

[5]  J. Mantz,et al.  Halothane and isoflurane increase spontaneous but reduce the N-methyl-D-aspartate-evoked dopamine release in rat striatal slices: evidence for direct presynaptic effects. , 1999, Anesthesiology.

[6]  A. Malhotra,et al.  Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach , 1998, Synapse.

[7]  U. Schotten,et al.  Halothane, But Not Isoflurane, Impairs the beta‐adrenergic Responsiveness in Rat Myocardium , 1998, Anesthesiology.

[8]  M. Eckenhoff,et al.  Quantitative autoradiography of halothane binding in rat brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[9]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  K. Sugiyama,et al.  Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases , 1997, Brain Research.

[11]  H. Benveniste,et al.  Extracellular glutamate and dopamine measured by microdialysis in the rat striatum during blockade of synaptic transmission in anesthetized and awake rats , 1997, Brain Research.

[12]  Christer Halldin,et al.  Effect of reserpine‐induced depletion of synaptic dopamine on [11C]Raclopride binding to D2‐dopamine receptors in the monkey brain , 1997, Synapse.

[13]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P B Hoffer,et al.  Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.

[15]  E. Abercrombie,et al.  Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats , 1996, Brain Research Bulletin.

[16]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[17]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J D Brodie,et al.  Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  Nobuko Mataga,et al.  Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey , 1994, Brain Research.

[20]  K. Chergui,et al.  Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brainin vivo , 1994, Neuroscience.

[21]  F. Gonon,et al.  Continuousin vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry , 1994, Neuroscience.

[22]  A. Fink-Jensen,et al.  Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[23]  R. Sunahara,et al.  Receptor‐receptor link in membranes revealed by ligand competition: Example for dopamine D1 and D2 receptors , 1994, Synapse.

[24]  J. Mantz,et al.  Effects of Volatile Anesthetics, Thiopental, and Ketamine on Spontaneous and Depolarizationevoked Dopamine Release from Striatal Synaptosomes in the Rat , 1994, Anesthesiology.

[25]  J S Fowler,et al.  Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels , 1993, Synapse.

[26]  E. Eger,et al.  The effect of halothane dose on striatal dopamine: an in vivo microdialysis study , 1993, Brain Research.

[27]  E. Borrelli,et al.  Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. , 1992, Brain research. Molecular brain research.

[28]  R. Wightman,et al.  Evoked Neuronal Activity Accompanied by Transmitter Release Increases Oxygen Concentration in Rat Striatum in vivo but Not in vitro , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Marc Laruelle,et al.  Amphetamine‐stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates , 1992, Synapse.

[30]  R. Aronstam,et al.  Influence of halothane on the interactions of serotonin1A and adenosine A1 receptors with G proteins in rat brain membranes. , 1991, Biochemical pharmacology.

[31]  J. Warter,et al.  Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat , 1991, Neuroscience Letters.

[32]  C. Halldin,et al.  Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain Membranes , 1990, Journal of neurochemistry.

[33]  U. Ungerstedt,et al.  An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats , 1990, Journal of Neuroscience Methods.

[34]  U. Ungerstedt,et al.  Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  S. Stone-Elander,et al.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.

[36]  L. Farde,et al.  Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  M. Phelps,et al.  In vivo [3H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  N. Koshikawa,et al.  Ketamine anaesthesia has no effect on striatal dopamine metabolism in rats , 1988, Brain Research.

[39]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[40]  F. Gonon.  Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry , 1988, Neuroscience.

[41]  J. Wikberg,et al.  Effects of Halothane and Other Chlorinated Hydrocarbons on α2-Adrenoceptors in the Mouse Cortex , 1987 .

[42]  T. Högberg,et al.  Synthesis of [methoxy-3H]- and [methoxy-11C]- labelled raclopride. Specific dopamine-D2 receptor ligands , 1987 .

[43]  R. Aronstam,et al.  Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat , 1987, Neuropharmacology.

[44]  B. Bunney,et al.  Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin , 1987, Brain Research.

[45]  T. Ljungberg,et al.  A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis , 1987, Brain Research.

[46]  U. Ungerstedt,et al.  Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. , 1986, European journal of pharmacology.

[47]  A. Ford,et al.  Influence of anaesthetics on rat striatal dopamine metabolism in vivo , 1986, Brain Research.

[48]  R. Aronstam,et al.  Halothane effects on muscarinic acetylcholine receptor complexes in rat brain. , 1986, Biochemical pharmacology.

[49]  J. Girault,et al.  Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats , 1986, Brain Research Bulletin.

[50]  J. Girault,et al.  Release of newly synthesized 3h-dopamine in the striatum: An adaptation of the push-pull cannula method to awake restrained and anesthetized rats , 1986, Brain Research Bulletin.

[51]  F. Gonon,et al.  Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum , 1985, Neuroscience.

[52]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  R. Wightman,et al.  Monitoring the Stimulated Release of Dopamine with In Vivo Voltammetry. I: Characterization of the Response Observed in the Caudate Nucleus of the Rat , 1984, Journal of neurochemistry.

[54]  F. Gonon,et al.  In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry. , 1984, Analytical chemistry.

[55]  T D Cradduck,et al.  National electrical manufacturers association , 1983, Journal of the A.I.E.E..

[56]  D. Sibley,et al.  Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. , 1982, The Journal of biological chemistry.

[57]  Y. Vulliemoz,et al.  Halothane Effect on Beta‐Adrenergic Receptors in Canine Myocardium , 1981, Anesthesia and analgesia.

[58]  J. Glowinski,et al.  Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways , 1979, Nature.

[59]  M. Baudry,et al.  In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. , 1977, Life sciences.

[60]  L. Saarnivaara,et al.  Effect of Ketamine Anaesthesia on the Content of Monoamines and their Metabolites in the Rat Brain , 1976, Acta anaesthesiologica Scandinavica.

[61]  Albert Gjedde,et al.  Physiological imaging of the brain with PET , 2001 .

[62]  N. Volkow,et al.  Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects , 1998, Neuropsychopharmacology.

[63]  S. Bischoff,et al.  Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies. , 1997, Journal of receptor and signal transduction research.

[64]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[65]  P. Seeman,et al.  Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain , 1989, Synapse.

[66]  P. Seeman,et al.  Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide. , 1984, Molecular pharmacology.

[67]  H. Jasper,et al.  A stereotaxic atlas of the diencephalon of the cat , 1960 .